These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14715550)

  • 21. Avidity determinations for Haemophilus influenzae Type b anti-polyribosylribitol phosphate antibodies.
    Romero-Steiner S; Holder PF; Gomez de Leon P; Spear W; Hennessy TW; Carlone GM
    Clin Diagn Lab Immunol; 2005 Sep; 12(9):1029-35. PubMed ID: 16148167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled study.
    Vesikari T; Forstén A; Desole MG; Ferrera G; Caubet M; Mesaros N; Boutriau D
    Pediatr Infect Dis J; 2013 May; 32(5):521-9. PubMed ID: 23190785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity of a Haemophilus influenzae type b-tetanus conjugate vaccine when administered separately or in combined vaccines for primary immunization in two consecutive national schedules in Turkey.
    Yüksel N; Beyazova U; Balci IF; Aksakal FN; Camurdan AD; Sahin F; Rota S
    Int J Infect Dis; 2012 May; 16(5):e354-7. PubMed ID: 22387144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five-year Antibody Persistence and Safety After a Single Dose of Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine in Haemophilus influenzae Type B-primed Toddlers.
    Booy R; Nolan T; Reynolds G; Richmond P; Nissen M; Marshall H; Stoney T; Van Der Wielen M; Kolhe D; Miller JM
    Pediatr Infect Dis J; 2015 Dec; 34(12):1379-84. PubMed ID: 26372451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children.
    Madhi SA; Kuwanda L; Saarinen L; Cutland C; Mothupi R; Käyhty H; Klugman KP
    Vaccine; 2005 Dec; 23(48-49):5517-25. PubMed ID: 16107294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity.
    Nociari MM; Shalev A; Benias P; Russo C
    J Immunol Methods; 1998 Apr; 213(2):157-67. PubMed ID: 9692848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
    Schlesinger Y; Granoff DM
    JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.
    Nix EB; Choi J; Anthes C; Gaultier GN; Thorgrimson J; Cox AD; Tsang RSW; McCready WG; Boreham D; Ulanova M
    PLoS One; 2018; 13(8):e0201282. PubMed ID: 30110339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemophilus influenzae type b antibodies in vaccinated and non-vaccinated children.
    Arvas A; Gur E; Bahar H; Torun MM; Demirci M; Aslan M; Kocazeybek B
    Pediatr Int; 2008 Aug; 50(4):469-73. PubMed ID: 19143969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison on the levels of human serum antibody against Neisseria meningitidis serogroup C measured using serum bactericidal assay and ELISA].
    Zhu BQ; Xu L; Zhou HJ; Shao ZJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 May; 33(5):521-4. PubMed ID: 22883183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inadequacy of colominic acid as an absorbent intended to facilitate use of complement-preserved baby rabbit serum in the Neisseria meningitidis serogroup B serum bactericidal antibody assay.
    Findlow J; Holland A; Martin D; Oster P; Balmer P; Borrow R
    Clin Vaccine Immunol; 2007 May; 14(5):556-61. PubMed ID: 17344344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of the Haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular pertussis/Hib combination vaccines.
    Denoël PA; Goldblatt D; de Vleeschauwer I; Jacquet JM; Pichichero ME; Poolman JT
    Clin Vaccine Immunol; 2007 Oct; 14(10):1362-9. PubMed ID: 17699836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial.
    Iro MA; Khatami A; Marshall AS; Pace D; Voysey M; McKenna J; Campbell D; Attard-Montalto S; Finn A; White C; Faust SN; Kent A; Heath PT; MacLeod E; Stanford E; Findlow H; Almond R; Bai X; Borrow R; Snape MD; Pollard AJ
    Lancet Infect Dis; 2015 Feb; 15(2):172-80. PubMed ID: 25577661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method.
    Jang MS; Sahastrabuddhe S; Yun CH; Han SH; Yang JS
    Microb Pathog; 2016 Aug; 97():19-26. PubMed ID: 27216239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines.
    Slack MH; Schapira D; Thwaites RJ; Burrage M; Southern J; Andrews N; Borrow R; Goldblatt D; Miller E
    J Infect Dis; 2001 Dec; 184(12):1617-20. PubMed ID: 11740740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout.
    Necchi F; Saul A; Rondini S
    PLoS One; 2017; 12(2):e0172163. PubMed ID: 28192483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of a conjugate vaccine against Haemophilus influenzae type b in splenectomized and nonsplenectomized patients with Cooley anemia.
    Cimaz R; Mensi C; D'Angelo E; Fantola E; Milone V; Biasio LR; Carnelli V; Zanetti AR
    J Infect Dis; 2001 Jun; 183(12):1819-21. PubMed ID: 11372038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b in human adult volunteers.
    Toraño G; Toledo ME; Baly A; Fernandez-Santana V; Rodriguez F; Alvarez Y; Serrano T; Musachio A; Hernandez I; Hardy E; Rodríguez A; Hernandez H; Aguilar A; Sánchez R; Diaz M; Muzio V; Dfana J; Rodríguez MC; Heynngnezz L; Verez-Bencomo V
    Clin Vaccine Immunol; 2006 Sep; 13(9):1052-6. PubMed ID: 16960118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.
    Pace D; Snape M; Westcar S; Hamaluba M; Yu LM; Begg N; Wysocki J; Czajka H; Maechler G; Boutriau D; Pollard AJ
    Pediatr Infect Dis J; 2007 Nov; 26(11):1057-9. PubMed ID: 17984816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization with Haemophilus influenzae type b-CRM(197) conjugate vaccine elicits a mixed Th1 and Th2 CD(4+) T cell cytokine response that correlates with the isotype of antipolysaccharide antibody.
    Kamboj KK; King CL; Greenspan NS; Kirchner HL; Schreiber JR
    J Infect Dis; 2001 Oct; 184(7):931-5. PubMed ID: 11528593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.